In one paragraphObservational study in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Sayar R AbdulkhakovDepartment of Internal Diseases, Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan 420008, Russia.ORCID 0000-0001-9542-3580 Maria I MarkelovaDepartment of Internal Diseases, Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan 420008, Russia.ORCID 0000-0001-7445-2091 Elizaveta R PonomarevaDepartment of Internal Diseases, Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan 420008, Russia.ORCID 0009-0006-7720-0897 Maria N SiniaginaDepartment of Internal Diseases, Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan 420008, Russia.ORCID 0000-0002-8138-9235 Dilyara R KhusnutdinovaDepartment of Internal Diseases, Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan 420008, Russia.ORCID 0000-0002-9982-9059 Olga V KupriyanovaDepartment of Internal Diseases, Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan 420008, Russia.
Rustam A AbdulkhakovDepartment of Hospital Therapy, Faculty of Medicine, Kazan State Medical University, Kazan 420012, Russia.
Tatyana V GrigoryevaDepartment of Internal Diseases, Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan 420008, Russia.ORCID 0000-0001-5314-7012 Funding
Tatarstan Academy of Sciences 12/2025-PD-KFU
6 · The paper itselfAbstract
The long-term impact of eradication therapy for
Indexed as
Butyric AcidGastrointestinal MicrobiomeHelicobacter InfectionsHelicobacter pyloriInulinMetabolomeAdultAnti-Bacterial AgentsFatty Acids, VolatileFecesFemaleHumansMaleMetabolomicsMetagenomeMetagenomicsAnti-Bacterial AgentsButyric AcidFatty Acids, VolatileInulinbutyric acideradication therapygut microbiotaHelicobacter pyloriinulinshort-chain fatty acidsZacofalk
Identifiers
PMID42883733
PMCPMC13665142
What OpenQuestion holds
Textmetadata
Read underepoch 390